It’s clear the world needs a different way of approaching addiction. That’s why we are so excited to bring on Rick Doblin the founder of MAPS, Multidisciplinary Association for Psychedelic Studies. Here’s here to talk to us about the trials and experiences he’s collected over the past 40 years to help advance FDA approval of psychedelics for therapeutic use in the U.S. and abroad. Learn about the proven healing benefits of MDMA and Psilocybin.